Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / Governments / Australia — Therapeutic Goods Administration
Entity

Australia — Therapeutic Goods Administration

Tracked across 3 events · 18 articles · First seen May 05, 2026 · Last active May 27, 2026

Sentiment
0
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (3)
4 0
Business
InnoCare orelabrutinib approved Australia
InnoCare Pharma announced that its novel Bruton's tyrosine kinase (BTK) inhibitor, orelabrutinib (HIBRUKA®), has been approved by the Australia — Therapeutic Goods Administration (TGA) in Australia. This approval provides a new treatment option for patients…
Impact: The Australia — Therapeutic Goods Administration (TGA) approved orelabrutinib in Australia, making it available as a new treatment option for Mantle Cell Lymphoma.
May 27, 2026 · 6 articles
4 0
Tech
Arrowhead Presents Positive Plozasiran Data
Arrowhead Pharmaceuticals presented new positive clinical data for Plozasiran at the 94th European Atherosclerosis Society Congress. The data support the use of Plozasiran in patients with moderate-to-severe renal impairment or moderate hepatic impairment without dose…
Impact: The Australian Australia — Therapeutic Goods Administration previously approved REDEMPLO (plozasiran), expanding its global reach.
May 26, 2026 · 6 articles
2 0
Business
Norgine PEDMARQSI TGA Australia Approval
May 05, 2026 · 6 articles
Key Actions (1)
100 Australia — Therapeutic Goods Administration approved drug InnoCare PharmaInnoCare orelabrutinib...
NEWSDESK
Track Australia — Therapeutic Goods Administration live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.